[HTML][HTML] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease
I Beltran-Hortelano, V Alcolea, M Font… - Bioorganic & medicinal …, 2022 - Elsevier
Chagas disease (CD) is a centenarian neglected parasitosis caused by the protozoan
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …
From Benznidazole to new drugs: Nanotechnology contribution in Chagas disease
DC Gomes, TS Medeiros, EL Alves Pereira… - International Journal of …, 2023 - mdpi.com
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …
Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products as Leishmania mexicana Inhibitors
LD González-Morales, A Moreno-Rodríguez… - Pharmaceutics, 2023 - mdpi.com
Cutaneous leishmaniasis (CL) is a public health problem affecting more than 98 countries
worldwide. No vaccine is available to prevent the disease, and available medical treatments …
worldwide. No vaccine is available to prevent the disease, and available medical treatments …
QSAR modeling for multi-target drug discovery: Designing simultaneous inhibitors of proteins in diverse pathogenic parasites
VV Kleandrova, L Scotti… - Frontiers in …, 2021 - frontiersin.org
Parasitic diseases remain as unresolved health issues worldwide. While for some parasites
the treatments involve drug combinations with serious side effects, for others, chemical …
the treatments involve drug combinations with serious side effects, for others, chemical …
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione …
A González-González, O Sánchez-Sánchez… - International Journal of …, 2022 - mdpi.com
American trypanosomiasis is a worldwide health problem that requires attention due to
ineffective treatment options. We evaluated n-butyl and isobutyl quinoxaline-7-carboxylate 1 …
ineffective treatment options. We evaluated n-butyl and isobutyl quinoxaline-7-carboxylate 1 …
Chloride substitution on 2-hydroxy-3, 4, 6-trimethoxyphenylchalcones improves in vitro selectivity on Trypanosoma cruzi strain Y
EP Magalhães, NDB Gomes, TA De Freitas… - Chemico-Biological …, 2022 - Elsevier
Chagas disease is a disease that is emerging in North America and Europe countries.
Benznidazole is the main drug available, but it has high toxicity and low efficacy in the …
Benznidazole is the main drug available, but it has high toxicity and low efficacy in the …
Trypanocidal potential of synthetic p-aminochalcones: In silico and in vitro evaluation
NDB Gomes, EP Magalhães, LR Ribeiro… - Bioorganic …, 2023 - Elsevier
Chagas disease (CD) is a neglected tropical disease of worldwide health concern, caused
by the flagellate protozoan Trypanosoma cruzi (T. cruzi), endemic in Latin America and …
by the flagellate protozoan Trypanosoma cruzi (T. cruzi), endemic in Latin America and …
Computational approaches for drug discovery against trypanosomatid-caused diseases
CA Pereira, M Sayé, C Reigada, AM Silber… - Parasitology, 2020 - cambridge.org
During three decades, only about 20 new drugs have been developed for malaria,
tuberculosis and all neglected tropical diseases (NTDs). This critical situation was reached …
tuberculosis and all neglected tropical diseases (NTDs). This critical situation was reached …
Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
CJ Bethencourt-Estrella, S Delgado-Hernández… - Pharmaceuticals, 2021 - mdpi.com
The neglected infection known as Chagas disease, caused by the protozoan parasite
Trypanosoma cruzi, results in more than 7000 deaths per year, with an increasing number of …
Trypanosoma cruzi, results in more than 7000 deaths per year, with an increasing number of …
In silico study identified methotrexate analog as potential inhibitor of drug resistant human dihydrofolate reductase for cancer therapeutics
Drug resistance is a core issue in cancer chemotherapy. A known folate antagonist,
methotrexate (MTX) inhibits human dihydrofolate reductase (hDHFR), the enzyme …
methotrexate (MTX) inhibits human dihydrofolate reductase (hDHFR), the enzyme …